MA53158A - METHODS FOR SCREENING AND IDENTIFYING AGENTS INHIBITING OR MODULATING THE NUCLEAR EXIT COMPLEX OF THE HERPES VIRUS - Google Patents

METHODS FOR SCREENING AND IDENTIFYING AGENTS INHIBITING OR MODULATING THE NUCLEAR EXIT COMPLEX OF THE HERPES VIRUS

Info

Publication number
MA53158A
MA53158A MA053158A MA53158A MA53158A MA 53158 A MA53158 A MA 53158A MA 053158 A MA053158 A MA 053158A MA 53158 A MA53158 A MA 53158A MA 53158 A MA53158 A MA 53158A
Authority
MA
Morocco
Prior art keywords
modulating
screening
methods
herpes virus
identifying agents
Prior art date
Application number
MA053158A
Other languages
French (fr)
Inventor
Jutta Eichler
Manfred Marschall
Yves Muller
Heinrich Sticht
Original Assignee
Aicuris Gmbh & Co Kg
Univ Friedrich Alexander Er
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Gmbh & Co Kg, Univ Friedrich Alexander Er filed Critical Aicuris Gmbh & Co Kg
Publication of MA53158A publication Critical patent/MA53158A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/03—Herpetoviridae, e.g. pseudorabies virus
    • C07K14/04—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/03—Herpetoviridae, e.g. pseudorabies virus
    • C07K14/05—Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/04—Varicella-zoster virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/05—Epstein-Barr virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA053158A 2018-07-20 2019-07-19 METHODS FOR SCREENING AND IDENTIFYING AGENTS INHIBITING OR MODULATING THE NUCLEAR EXIT COMPLEX OF THE HERPES VIRUS MA53158A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18184806 2018-07-20

Publications (1)

Publication Number Publication Date
MA53158A true MA53158A (en) 2021-05-26

Family

ID=63014438

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053158A MA53158A (en) 2018-07-20 2019-07-19 METHODS FOR SCREENING AND IDENTIFYING AGENTS INHIBITING OR MODULATING THE NUCLEAR EXIT COMPLEX OF THE HERPES VIRUS

Country Status (7)

Country Link
US (1) US12276665B2 (en)
EP (1) EP3823979B8 (en)
AU (2) AU2019304526B2 (en)
CA (1) CA3106833A1 (en)
ES (1) ES3005559T3 (en)
MA (1) MA53158A (en)
WO (1) WO2020016433A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7802256B2 (en) 2020-08-05 2026-01-20 サニオナ アクティーゼルスカブ Difluoromethyl-pyridin-2-yltriazole

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
ES2087997T3 (en) 1990-01-12 1996-08-01 Cell Genesys Inc GENERATION OF XENOGENIC ANTIBODIES.
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
JPH06508511A (en) 1990-07-10 1994-09-29 ケンブリッジ　アンティボディー　テクノロジー　リミティド Method for producing specific binding pair members
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5770358A (en) 1991-09-18 1998-06-23 Affymax Technologies N.V. Tagged synthetic oligomer libraries
EP0746609A4 (en) 1991-12-17 1997-12-17 Genpharm Int Transgenic non-human animals capable of producing heterologous antibodies
DE69333087T2 (en) 1992-10-01 2004-05-06 The Trustees Of Columbia University In The City Of New York COMPLEX COMBINATORY CHEMICAL BANKS WITH MARKINGS
NZ276860A (en) 1993-11-02 1997-09-22 Affymax Tech Nv Apparatus and its use for synthesising diverse molecular products on substrates
CA2189634A1 (en) 1994-05-06 1995-11-16 John J. Baldwin Combinatorial dihydrobenzopyran library
US5663046A (en) 1994-06-22 1997-09-02 Pharmacopeia, Inc. Synthesis of combinatorial libraries
EP1135498B1 (en) * 1998-11-18 2008-01-23 Genentech, Inc. Antibody variants with higher binding affinity compared to parent antibodies
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
CA2645507A1 (en) * 2006-03-10 2007-09-20 The Regents Of The University Of California Vaccine for viruses that cause persistent or latent infections
NZ600974A (en) * 2009-12-23 2014-08-29 4Antibody Ag Binding members for human cytomegalovirus
CA3128572C (en) * 2010-05-05 2023-02-21 Christian Thirion Vaccine against beta-herpesvirus infection and use thereof
CA2890061A1 (en) * 2012-12-04 2014-06-12 Merck Sharp & Dohme Corp. Conditional replicating viral vectors
US20150051090A1 (en) * 2013-08-19 2015-02-19 D.E. Shaw Research, Llc Methods for in silico screening
WO2017157969A1 (en) * 2016-03-14 2017-09-21 Redbiotec Ag Means and methods for treating hsv
JP7614842B2 (en) * 2018-04-03 2025-01-16 サノフイ Antigenic Epstein-Barr Virus Polypeptides

Also Published As

Publication number Publication date
AU2019304526A1 (en) 2020-12-24
US20210396761A1 (en) 2021-12-23
AU2019304526B2 (en) 2024-09-19
CA3106833A1 (en) 2020-01-23
US12276665B2 (en) 2025-04-15
EP3823979C0 (en) 2024-12-18
EP3823979B8 (en) 2025-02-26
AU2024216501A1 (en) 2024-09-19
EP3823979A1 (en) 2021-05-26
EP3823979B1 (en) 2024-12-18
ES3005559T3 (en) 2025-03-14
WO2020016433A1 (en) 2020-01-23

Similar Documents

Publication Publication Date Title
EP3443323A4 (en) CLOSED DROPLET SORTER AND RELATED METHODS OF USE
EP3924373A4 (en) COMPOSITIONS AND METHODS FOR IDENTIFYING ANTIGEN-SPECIFIC T LYMPHOCYTES
EP3697297A4 (en) SYSTEMS AND METHODS FOR IDENTIFYING BIOLOGICAL STRUCTURES ASSOCIATED WITH NEUROMUSCULAR SOURCE SIGNALS
EP3622443A4 (en) SYSTEMS AND METHODS FOR THE ELECTRONIC IDENTIFICATION OF PLANT SPECIES
EP3408640A4 (en) METHODS AND APPARATUS FOR IDENTIFYING SAMPLE CONTAINER FROM SEVERAL SIDE VIEWS
EP3752166A4 (en) TRIALCYNE BINDING AGENTS AND METHODS OF USE
EP3610269A4 (en) METHODS AND APPARATUS FOR DETERMINING THE NUMBER OF MARKERS DURING A SAMPLE CHARACTERIZATION
EP3408646A4 (en) METHODS AND APPARATUS FOR CHARACTERIZING SAMPLE CONTAINER AND SAMPLE
MA46200A (en) METHODS FOR USING A BISPECIFIC ANTIBODY WHICH RECOGNIZES COAGULATION FACTOR IX AND / OR COAGULATION FACTOR IX ACTIVATED AND COAGULATION FACTOR X AND / OR COAGULATION FACTOR X ACTIVATED
EP3709595A4 (en) SECURE ROUTE IDENTIFICATION PROCESS AND DEVICE
MA56121A (en) METHODS FOR IDENTIFYING THERAPEUTIC PROTEIN ATTRIBUTES
EP3488018A4 (en) METHODS AND COMPOSITIONS FOR THE IDENTIFICATION OF PROTEINS
EP3484488A4 (en) ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
EP3472358A4 (en) EPIGENETIC ANALYSIS METHODS AND SYSTEM
EP3487998A4 (en) COMPOSITIONS AND METHODS FOR IDENTIFYING RNA-BINDING POLYPEPTIDE TARGETS
EP3772935A4 (en) IMPROVED ULTRA-RAPID COOLING SYSTEM AND METHODS OF USE
EP3856905A4 (en) METHODS AND COMPOSITIONS FOR INCREASING PROTEIN EXPRESSION AND/OR TREATING HAPLO-DEFICIENCY DISORDER
EP3631504C0 (en) APPARATUS AND METHODS FOR SYNTHETIC APERTURE RADAR IMAGING
EP3448274A4 (en) GUIDANCE DEVICE AND METHODS OF USE THEREOF
EP3796599A4 (en) EVALUATION SYSTEM AND EVALUATION PROCESS
EP3714397A4 (en) METHOD AND SYSTEM FOR IDENTIFYING THE AUTHENTICITY OF AN OBJECT
EP3440595A4 (en) SYSTEMS AND METHODS FOR IDENTIFYING WASTE
EP3930618A4 (en) IDENTITY VERIFICATION DEVICE AND METHODS
EP3958727A4 (en) PROTEIN SPATIAL ANALYSIS METHODS AND KITS
EP4081939A4 (en) PROCEDURE FOR IDENTIFYING THE AUTHENTICITY OF AN OBJECT